Cargando…
Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage (“Neuroprotection”)
The term “neuroprotection” is often misused, overused, or misunderstood. A reasonable definition of neuroprotection refers to the preservation of “neuronal structure and/or function.” Although our knowledge about the cellular and molecular mechanisms of neurodegeneration has expanded, experimental s...
Autores principales: | Wiendl, Heinz, Elger, Christian, Förstl, Hans, Hartung, Hans-Peter, Oertel, Wolfgang, Reichmann, Heinz, Schwab, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404462/ https://www.ncbi.nlm.nih.gov/pubmed/25773662 http://dx.doi.org/10.1007/s13311-015-0348-8 |
Ejemplares similares
-
Prominent T-Cell Responses against the Acetylcholine Receptor ε Subunit in Myasthenia Gravis
por: Neuhaus, Oliver, et al.
Publicado: (2019) -
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
por: Warnke, Clemens, et al.
Publicado: (2010) -
Benefit–Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
por: Comi, Giancarlo, et al.
Publicado: (2017) -
CSF and Serum Biomarkers of Cerebral Damage in Autoimmune Epilepsy
por: Nass, Robert Daniel, et al.
Publicado: (2021) -
Neuroprotective Properties of 4-Aminopyridine
por: Dietrich, Michael, et al.
Publicado: (2021)